Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers

Seminars in Thrombosis and Hemostasis

Volumn 26, Issue 1, 2000, Pages 17-22

  Wada, Hideo ^a   Gabazza, Esteban ^a   Nakasaki, Takahiro ^a   Shimura, Minori ^a   Hiyoyama, Kazuyo ^a   Deguchi, Katsumi ^a   Nishikawa, Masakatsu ^a   Sakuragawa, Nobuo ^b   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

DIC; PPIC; Pre DIC; SFM; TAT

Indexed keywords

ANTIPLASMIN; D DIMER; FIBRIN MONOMER; PLASMIN; THROMBIN ANTITHROMBIN COMPLEX;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; ANTITHROMBIN III; BIOLOGICAL MARKERS; DISSEMINATED INTRAVASCULAR COAGULATION; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; PARTIAL THROMBOPLASTIN TIME; PEPTIDE HYDROLASES; PLASMIN; THROMBOPHILIA;

EID: 0034006732     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. 1. Bick RL. Disseminated intravascular coagulation and related syndromes: A clinical review. Semin Thromb Hemost 1998;14: 299-338
2. 2. Müller-Berghaus G. Pathophysiologic and biochemical events in disseminated intravascular coagulation: Dysregulation of procoagulant and anticoagulant pathways. Semin Thromb Hemost 1989;15:58-98
3. 3. Kobayashi N, Maegawa K, Takada M, Tanaka H, Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol 1987;49: 265-275
4. 4. Wada H, Minamikawa K, Wakita Y, et al. Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol 1994;43:265-275
5. 5. Ohno H, Kambayashi J, Chang SW, Kosaki G. FOY;[ethyl p(6-guanidino-hexanoxyloxy) benzoate] methanesulfonate as a serine protease inhibitor. II. In vivo effect on coagulofibrinolytic system in comparison with heparin or aprotinin. Thromb Res 1980;24:455-452
6. 6. Sakuragawa N, Hasegawa H, Maki M, Nakagawa M, Nakashima M. Clinical evaluation of low-molecular weight heparin (FR-860) on disseminated intravascular coagulation (DIC). A multicentric cooperative double blind trial in comparison with heparin. Thromb Res 1993;72:475-500
7. 7. Larcan A, Lambert H, Gerard A. Treatment of Consumption Coagulopathies. Paris: Masson Publishing, 1987:165-181
8. 8. Wada H, Wakita Y, Nakase T, et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 1995;74:848-852
9. 9. Rylatt DB, Blake AS, Cottis LE, et al. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983;31:767-778
10. 10. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1987;59:101-106
11. 11. Mimuro J, Koike Y, Sumi Y, Aoki N. Monoclonal antibodies to discrete regions in α2-plasmin inhibitor. Blood 1987;69: 446-452
12. 12. Wada H, Wakita Y, Nakase T, et al. Increased plasma soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Am J Hematol 1996;51:255-260
13. 13. Wada H, Tomeoku M, Deguchi A, et al. Anticoagulant activity in cell homogenate of adult T cell leukemia. Thromb Haemost 1988;59:197-201
14. 14. Wada H, Sakuragawa N, Shiku H. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients. Semin Thromb Hemost 1998;24:293-297
15. 15. Wada H, Nakase T, Nakaya R, et al. Elevated plasma tissue factor antigen levels in patients with disseminated intravascular coagulation. Am J Hematol 1994;45:232-236
16. 16. Shimura M, Wada H, Wakita Y, et al. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation. Am J Hematol 1996;52: 165-170
17. 17. Wada H, Minamikawa K, Wakita Y, et al. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation. Am J Hematol 1993;44:85-88
18. 18. Wada H, Mori Y, Shimura M, et al. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries. Am J Hematol 1998;58:189-194